Parabilis Medicines, Inc. ·

PBLS 8-K 2026-09-02

Parabilis Medicines, Inc. (PBLS) 8-K dated 2026-09-02 — accession 0001193125-26-380171. This URL is the filing, not the PBLS hub.

Parabilis Medicines, Inc. (PBLS) common stock.

Parabilis Medicines, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-380171.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PBLS revenue for 2026-06-30 was $148.0K. Net income was -$97.8M. PBLS currently screens at market cap $0.

Not investment advice. The PBLS SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR